coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    One Ellesmere Port PCN, Cheshire West and Chester (LAD) · Health Inequalities Profile

    PCN U85986 · NHS Cheshire and Merseyside Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    72,232

    Registered population

    60.6% aged 18–64

    19.2%

    Aged 65+

    ICB 19.0% · England 17.9%

    4.2%

    Ethnic minority (non-White)

    1.8% Asian · England 9.6%

    37.2%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~21,589

    Core20 residents (est.)

    Resident basis; registered basis ~28,357 · see page 3

    12,010

    Hypertension register

    +7.63% in 3 yrs · England +5.60%

    728

    SMI register

    19.3% of Cheshire West and Chester (LAD)'s

    1,717

    COPD register

    Reviews +1.39% in 3 yrs

    Forecast to 2030

    14,360

    Hypertension patients, 2030

    +2,350 on today

    74.2%

    QRISK ≥20% on statins, 2030

    +2.49pp over 3 yrs

    4.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    49.3%
    Asthma annual reviews sit well below England.

    Annual asthma reviews reach 49.3% (-16.4 percentage points versus England's 65.7%), leaving about 2,500 of 4,952 registered patients unreviewed.

    66.6%
    Hypertension treatment to target lags all benchmarks.

    Hypertension control is 66.6% against 70.3% in England, trailing both under-80 (64.9% vs 67.8%) and 80+ (76.6% vs 81.2%) thresholds.

    69.0%
    Lipid-lowering therapy exceeds local and national rates.

    Lipid-lowering therapy covers 69.0% of patients with QRISK ≥ 20% (England 63.6%) and 75.5% of CKD patients (England 70.3%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older adults comprise 19.2% of registered patients alongside 20.2% aged 0 to 17

    Across six practices, ONE ELLESMERE PORT PCN registers 72,232 patients. Those aged 65+ account for 19.2% (13,876 patients), below Cheshire West and Chester (20.3%), but above NHS Cheshire and Merseyside ICB (19.0%) and England (17.9%). Children aged 0–17 represent 20.2% (14,594 patients), exceeding Cheshire West and Chester (18.5%), NHS Cheshire and Merseyside ICB (19.2%) and England (19.6%). Ethnicity data reflects Census usual residents, not GP registrations: 95.8% are White (Cheshire West and Chester 95.3%, NHS Cheshire and Merseyside ICB 93.0%, England 81.1%), with a 4.2% ethnic minority share.

    Age profile

    0–1720.2%
    18–6460.6%
    65+19.2%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White95.8%
    Asian1.8%
    Mixed1.3%
    Black0.6%
    Other0.6%

    Older people · falls rows are Cheshire West and Chester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire West and Chester LA)2,1092,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.0%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.5%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire West and Chester LA)8931,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire West and Chester LA)14.918.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 5.2, yet Core20 share spans 60.0 pp across practices

    The PCN Core20 registered share is 37.2%, exceeding Cheshire West and Chester (15.7%), the ICB (31.9%), and England (21.0%), with an average IMD decile of 5.2. The range across captured practices is 60.0 pp. Great Sutton Medical Centre has a Core20 share of 23.4%, while Westminster Surgery reaches 83.3%. Old Hall Surgery records 69.1%, and York Road Group Practice records 62.1% with the highest volume at 7,474 estimated patients. Denominators must be reconciled, as practice estimates sum to 28,357 registered patients compared with 21,589 resident Core20 people.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Westminster83.3% · 3,250 patients
    Old Hall69.1% · 3,958 patients
    York Road62.1% · 7,474 patients
    Whitby Health33.5% · 5,317 patients
    Hope Farm25.1% · 3,765 patients
    Great Sutton23.4% · 4,593 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    728

    SMI register

    1.01% recorded prevalence

    506

    Learning disability register

    0.70% recorded prevalence

    20

    Care homes, 731 beds

    In the PCN catchment

    9.6%

    Provide unpaid care

    Cheshire West and Chester (LAD), Census 2021

    The PCN records 728 patients on its severe mental illness register (1.0%, matching England) and 506 with learning disabilities (0.7%, above England's 0.6%), alongside 20 care homes with 731 catchment beds. Annual physical checks trail England for blood pressure (78.1% vs 83.4%) and BMI (78.4% vs 82.1%). Physical check rates trailing national benchmarks could reflect recall or scheduling barriers to examine locally.

    Severe mental illness: physical health checks

    On the 728-patient severe mental illness register, annual blood pressure checks (78.1% vs England 83.4%) and BMI recording (78.4% vs England 82.1%) both trail national rates. Coordinated outreach is required to close physical health monitoring gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    12,010

    Hypertension register

    +7.63%

    Register growth, 3 yrs

    Cheshire West and Chester (LAD) +6.60% · England +5.60%

    +5.83pp

    BP control, under 80

    ≤140/90 · +0.85pp aged 80+

    +2,350

    More patients by 2030

    Forecast 14,360 (19.25%)

    Hypertension case-finding and control

    Hypertension prevalence is 16.6% (12,010 patients), above England (15.2%) but below Cheshire West and Chester (17.0%) and the ICB (16.8%), spanning from 11.4% at Westminster Surgery to 19.6% at Whitby Health Partnership. Crude unadjusted register gap scenarios range from -1,009 to +246 patients. Treatment to target reaches 66.6% against 70.3% in England and 68.9% in the borough, with under-80 control at 64.9% (England 67.8%) and aged 80+ control at 76.6% (England 81.2%). Recent blood pressure readings reach 88.4% (England 90.0%). Blood pressure control is below England across both age cohorts, so prioritising systematic blood pressure recall and titration review is an immediate operational opportunity.

    Lipids and statins

    Lipid-lowering therapy reaches 69.0% for patients with QRISK ≥ 20% (England 63.6%, borough 63.8%) and 75.5% for CKD (England 70.3%). Statin treatment for diabetes with prior cardiovascular disease is 86.3% (England 84.4%). Higher therapy rates than England across primary and secondary prevention cohorts indicate an opportunity to sustain strong treatment coverage for high-risk patients.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026139,946£1.40£1.71£1.86£195,924
    Cardiovascular (all), 2025192,905£4.89£4.37£3.33£943,305

    In 2026, 139,946 lipid-regulating items were prescribed at £1.40 per item (£195,924 spend), below England (£1.86), Cheshire West and Chester (£1.44) and the ICB (£1.71), spending £64,375 less than at England's unit cost. Lower unit cost than regional and national benchmarks keeps item expenditure down, so sustaining this position while maintaining clinical appropriateness is the key priority.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.22%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −3.01%

    Asthma prevalence, PCN 3-yr % change

    Recorded asthma prevalence is 7.3% (4,952 patients) against 6.6% in England, with youth prescribing at 2,466 items per 1,000 aged 5-19 versus 1,488 in England. However, annual asthma reviews fell 2.2% over three years (England +4.4%) to 49.3% (England 65.7%), leaving about 2,500 patients unreviewed. COPD reviews similarly lag at 67.0% against England's 76.4%, despite 2.4% prevalence (England 1.9%). Slower review completion alongside high prescribing may reflect recall capacity constraints to examine locally.

    Cancer register and children's immunisation

    The cancer register has 3,106 patients (4.3% prevalence vs England 3.8%), but three-year growth of +4.1% trailed England (+9.0%). In childhood immunisations, MMR dose 1 coverage reaches 97.1% at age 5, yet dose 2 falls 10.3 pp to 86.8%, with the gap widening to 22.8 pp at Old Hall Surgery. This drop-off indicates second-dose follow-up is an operational priority to protect coverage prior to school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.2%

    England 91.0%

    6-in-1 complete primary course at 24 months93.4%

    England 92.2%

    MMR dose 1 at 24 months92.2%

    England 88.3%

    MMR dose 2 at age 586.8%

    England 82.8%

    4-in-1 pre-school booster at age 586.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of cancers with a known stage (7,482 of 13,490) were diagnosed at stage 1 or 2, in line with England (55.3%) but 19.5 pp below the 75.0% national ambition by 2028. Known-stage share was 72.8% (13,490 of 18,522 registered cancers). Reaching 75.0% would require about 2,640 additional early-stage diagnoses annually across the ICB, where early staging rose +2.6 pp between 2013 and 2022. Locally, PCN cancer register growth was +4.1% over 2023 to 2025, trailing England (+9.0%) and the ICB (+9.3%), which could reflect under-coding or slower recording that local clinical audit could test.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Countess of Chester Hospital NHS Foundation Trust achieved 87.4% on the 28-day faster diagnosis standard, exceeding the 75.0% target and ahead of North Cheshire and Mersey NHS Foundation Trust (80.2%), Liverpool University Hospitals NHS Foundation Trust (75.5%), the ICB (77.2%) and England (79.3%). On the 62-day standard, Countess of Chester reached 83.3% (standard 85.0%), above the ICB (76.2%) and England (71.2%). Diagnostic 6+ week waits stood at 11.3% for MRI and 4.2% for CT, below England (21.4% and 9.9%), representing provider activity rather than PCN-specific performance.

    Pathways within standard (%)Countess of ChesterLiverpoolNorth Cheshire and MerseyCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)87.3775.4780.2177.2579.32
    31-day treatment (96%)93.4890.5198.1795.7192.50
    62-day referral to treatment (85%)83.2873.2683.6776.2371.16
    Diagnostic waits over 6 weeks (%)Countess of ChesterLiverpoolNorth Cheshire and MerseyEngland
    MRI11.266.420.5321.40
    CT4.180.712.329.92
    Echocardiography31.4412.5528.0428.48
    Colonoscopy26.4433.1415.9830.83
    Gastroscopy27.5244.9920.2429.02
    All 15 DM01 tests20.1611.506.3423.14
    Community services activityCheshire West and Chester residentsCheshire and Merseyside ICB
    Care contacts47,655541,280
    Referrals10,32597,150
    Patients with a contact18,585146,240

    Community services (residents of Cheshire West and Chester), Jun 2026 (provisional). In June 2026, adults aged 65 and over accounted for 52.7% of all community service contacts among Cheshire West and Chester residents (25,095 of 47,655 contacts). This highlights significant borough-wide community workload concentrated in older adults, though these figures represent local authority resident activity rather than PCN-level delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Hope Farm11125.165.1%76.9%88.1%
    York Road11162.158.2%74.7%85.3%
    Old Hall Surgery10869.158.7%66.7%79.0%
    Great Sutton11423.443.2%74.4%76.1%
    Whitby Health10833.552.3%60.7%67.2%
    Westminster11383.362.8%77.9%67.0%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire West and Chester (LAD)AssetPCNCheshire West and Chester (LAD)
    Care homes (catchment)20 (731 beds)n/aSchools (catchment)71n/a
    Children's centres315Places of worship23231
    Libraries316Food banks (VCS)11
    Homelessness support (VCS)11Day centres (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)1270
    Primary academies946Special schoolsn/a5

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    Asthma reviews in the last 12 months reach 49.3% on the 4,952-patient register (7.3% QOF prevalence, denominator incl. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension titration and case-finding review

    Hypertension treatment to target is 66.6% (England 70.3%, borough 68.9%; under-80s 64.9% vs 67.8%; 80+ 76.6% vs 81.2%), with a crude register gap range of -1,009 to +246 patients. For discussion: practices could run pharmacist-led recall and medication titration clinics alongside opportunistic blood pressure checks. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Combined SMI physical health checks

    On the 728-patient SMI register (1.0% prevalence), annual blood pressure checks reach 78.1% (England 83.4%, borough 81.0%, ICB 81.3%) and BMI checks reach 78.4% (England 82.1%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health checks (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall and titration (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    MMR second dose recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register and screening audit (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Hypertension titration and case-finding review (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients treated to targetCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Combined SMI physical health checks (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15